Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Tuesday, March 31, 2026.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2026 (2026-03-31): -540.06%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
-198.08%
RETURN ON EQUITY (ROE) AVG 3Y
-128.99%
RETURN ON EQUITY (ROE) AVG 5Y
-98.04%
RETURN ON EQUITY (ROE) AVG 10Y
-90.53%
RETURN ON EQUITY (ROE) AVG 15Y
-102.41%
RETURN ON EQUITY (ROE) AVG 20Y
-133.38%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Cytosorbents Corporation
Market Cap
$12.46M
Return on Equity (ROE)
N/A
TTM Avg
-198.08%
3Y Avg
-128.99%
5Y Avg
-98.04%
Market Cap
$12.63M
Return on Equity (ROE)
N/A
TTM Avg
-201.97%
3Y Avg
-21.23%
5Y Avg
365.72%
Market Cap
$11.95M
Return on Equity (ROE)
N/A
TTM Avg
-43.97%
3Y Avg
-160.70%
5Y Avg
-188.29%
Market Cap
$13.34M
Return on Equity (ROE)
-74.73%
TTM Avg
-265.78%
3Y Avg
-138.63%
5Y Avg
-109.18%
Market Cap
$11.42M
Return on Equity (ROE)
-37052.06%
TTM Avg
-237.80%
3Y Avg
-258.91%
5Y Avg
-310.30%
Market Cap
$11.41M
Return on Equity (ROE)
-106.87%
TTM Avg
-250.57%
3Y Avg
-230.96%
5Y Avg
-240.83%
Market Cap
$13.55M
Return on Equity (ROE)
-186.95%
TTM Avg
1198.98%
3Y Avg
241.18%
5Y Avg
112.17%
Market Cap
$13.62M
Return on Equity (ROE)
-101.66%
TTM Avg
-140.38%
3Y Avg
-131.64%
5Y Avg
-101.94%
Market Cap
$11.01M
Return on Equity (ROE)
-85.82%
TTM Avg
-222.53%
3Y Avg
-140.00%
5Y Avg
-73.12%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytosorbents Corporation (CTSO) | $12.46M | N/A | -198.08% | -128.99% | -98.04% |
| Dare Bioscience, Inc. (DARE)vs › | $12.63M | N/A | -201.97% | -21.23% | 365.72% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.95M | N/A | -43.97% | -160.70% | -188.29% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.34M | -74.73% | -265.78% | -138.63% | -109.18% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.42M | -37052.06% | -237.80% | -258.91% | -310.30% |
| Biofrontera Inc. (BFRI)vs › | $11.41M | -106.87% | -250.57% | -230.96% | -240.83% |
| Vyome Holdings, Inc. (HIND)vs › | $13.55M | -186.95% | 1198.98% | 241.18% | 112.17% |
| IN8bio, Inc. (INAB)vs › | $13.62M | -101.66% | -140.38% | -131.64% | -101.94% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.01M | -85.82% | -222.53% | -140.00% | -73.12% |
| BioVie Inc. (BIVI)vs › | $10.86M | -214.92% | -46.13% | -156.76% | -652.77% |
ROE
N/A
ROA
-48.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-03-31 | -540.06% |
| 2025-12-31 | -138.88% |
| 2025-09-30 | -117.35% |
| 2025-06-30 | -84.15% |
| 2025-03-31 | -109.95% |
| 2024-12-31 | -185.48% |
| 2024-09-30 | -145.02% |
| 2024-06-30 | -153.62% |
| 2024-03-31 | -145.66% |
| 2023-12-31 | -123.77% |
| 2023-09-30 | -126.62% |
| 2023-06-30 | -109.76% |
| 2023-03-31 | -107.66% |
| 2022-12-31 | -92.76% |
| 2022-09-30 | -105.65% |
| 2022-06-30 | -74.77% |
| 2022-03-31 | -52.96% |
| 2021-12-31 | -39.24% |
| 2021-09-30 | -22.56% |
| 2021-06-30 | -13.93% |
| 2021-03-31 | -11.07% |
| 2020-12-31 | -9.89% |
| 2020-09-30 | -13.85% |
| 2020-06-30 | -70.53% |
| 2020-03-31 | -83.67% |
| 2019-12-31 | -563.63% |
| 2019-09-30 | -307.68% |
| 2019-06-30 | -145.88% |
| 2019-03-31 | -127.29% |
| 2018-12-31 | -101.63% |
| 2018-09-30 | -74.51% |
| 2018-06-30 | -64.95% |
| 2018-03-31 | -64.37% |
| 2017-12-31 | -74.98% |
| 2017-09-30 | -88.24% |
| 2017-06-30 | -113.56% |
| 2016-09-30 | -690.92% |
| 2016-06-30 | -248.67% |
| 2016-03-31 | -83.83% |
| 2015-12-31 | -99.04% |
| 2015-09-30 | -118.91% |
| 2015-06-30 | -84.49% |
| 2015-03-31 | -135.16% |
| 2014-12-31 | -235.21% |
| 2012-09-30 | -362.52% |
| 2012-06-30 | -912.20% |
| 2011-09-30 | -424.61% |
| 2011-06-30 | -199.18% |
| 2011-03-31 | -273.99% |
| 2010-03-31 | -801.94% |
| 2009-12-31 | -215.90% |
| 2009-09-30 | -835.10% |
| 2009-06-30 | -359.71% |
| 2009-03-31 | -188.15% |
| 2008-12-31 | -127.91% |
| 2008-09-30 | -102.35% |
| 2008-06-30 | -92.17% |
| 2007-09-30 | -788.21% |
| 2007-06-30 | -743.07% |
| 2007-03-31 | -614.34% |
| 2006-12-31 | -282.18% |
